In a recent communication received by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) from the Embassy of India in Venezuela, a new opportunity has emerged for Indian pharmaceutical companies. The Venezuelan Ministry of Education has expressed a requirement for essential medicines, and Indian firms are being invited to meet this demand.
India and Venezuela have a growing pharmaceutical trade relationship, driven by Venezuela's need for affordable medicines and India's strong generic drug production capabilities.
Pharmexcil has urged its member companies, particularly those with manufacturing approvals from Stringent Regulatory Authorities (SRAs), to come forward and express their willingness to supply the listed medicines. This initiative is being facilitated through a Google form, and timely responses are crucial for onward submission to the Commerce Embassy of India in Caracas.
The list of required medicines has been shared with Pharmexcil for dissemination among eligible member companies. Only those firms with the capacity to supply the required medicines and with valid SRA approvals are requested to participate. The intention is to ensure quality and compliance with international standards, in line with Venezuela’s healthcare needs.
Pharmexcil emphasized that this is a valuable opportunity for Indian pharmaceutical exporters to strengthen their presence in the Latin American market, particularly in Venezuela. Interested companies are advised to respond as soon as possible through the designated Google form, enabling further coordination with the Embassy of India in Caracas.
Member companies are encouraged to take advantage of this export opportunity, which not only supports India’s trade interests but also contributes to global health cooperation.
The Venezuelan government has expressed strong interest in enhancing its pharmaceutical ties with India. Venezuela's growing demand for cost-effective medicines, especially for the treatment of chronic diseases, is a driving factor behind the country’s interest in Indian pharmaceutical exports.
These medicine are used for the treatment of range of common disorders, critical conditions and diseases including, fever, muscle pain, low blood sugar (hypoglycemia), blood clotting, hypertension, dehydration from diarrhoea, vomiting, excessive sweating, blood loss from trauma, surgery, or haemorrhage, diabetic nephropathy, stroke, asthma, chronic obstructive pulmonary disease (COPD), rheumatologic diseases, epilepsy, bacterial infections, nausea, vomiting, gastroparesis, gastroesophageal reflux disease, angina (heart-related chest pain), arrhythmia, hypertensive emergency, subarachnoid haemorrhage, anal fissure, infections of the reproductive system, gastrointestinal (GI) tract, skin, heart, bone, joint, lung, blood, nervous system, treat certain sexually transmitted diseases (STDs), allergic rhinitis, urticaria, allergic conjunctivitis, pneumonia, urinary tract infections, gonorrhoea, Lyme disease and schizophrenia among others.
Name of the medicines required by the Venezuelan Ministry of Education are acetaminofen 500mg, folic acid, valproic acid, amoxicillin, aspirin 81mg, atorvastatin 20mg, azithromycin, bassillus clausi, betametasone, bromexin, budesonide, calcium, candesartan 16mg tab, candesartan 32mg tab, candesartan 8mg tab, carbamazepine, cephadroxyl, cefixime, cetirizine, cinnarizine, ciprofloxacin, magnesium citrate, clobetasol, clopidogrel 75mg, chlorphemidamine, chlorthalidone, dexamethasone, escitalopram, haloperidol, hydrochlorothiazide 25mg, artificial tears drops, levetiracetam, carbidopa and levodopa, losartan potassium 100mg, metoclopramide drops, metronidazole, nimodipine, olmesartan, omeprazole 20mg, paracetamol, pentoxifylline, prednisone, pregabalin, quetiapine 200mg, ribaxobaran, oral rehydration salts, dextrose 5% in water and Ringer's solution among others.
|